Incline Therapeutics Nets First Venture Capital
Wednesday, June 23, 2010 5:58:00 AM PDT | VentureDeal Staff
Redwood City, California -- Pharmaceutical company Incline Therapeutics (no website) has secured $43 million in its first round of venture capital financing.
Incline Therapeutics says that it is focused on the development fentanyl iontophoretic transdermal system.
Frazier Healthcare Ventures led the round, which also included 5AM Ventures, Technology Partners, Adams Street Partners, Saints Capital and Emergent Medical Partners. Proceeds purposes were not disclosed.
Email Page | Print Page